PT  - JOURNAL ARTICLE
AU  - L. Philip Schumm
AU  - Mihai C. Giurcanu
AU  - Kenneth J. Locey
AU  - Jean Czerlinski Ortega
AU  - Zhenyu Zhang
AU  - Robert L. Grossman
TI  - Racial/Ethnic Disparities in the Observed COVID-19 Case Fatality Rate Among the U.S. Population
AID  - 10.1101/2022.03.01.22271708
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.03.01.22271708
4099  - http://medrxiv.org/content/early/2022/03/02/2022.03.01.22271708.short
4100  - http://medrxiv.org/content/early/2022/03/02/2022.03.01.22271708.full
AB  - Purpose During the initial 12 months of the pandemic, racial and ethnic disparities in COVID-19 death rates received considerable attention but it has been unclear whether disparities in death rates were due to disparities in case fatality rates (CFRs), incidence rates or both. We examined differences in observed COVID-19 case fatality rates (CFRs) between U.S. Whites, Blacks/African Americans and Latinx during this period.Methods Using data from the COVID Tracking Project (CTP) and the CDC’s COVID-19 Case Surveillance Public Use dataset, we calculated CFR ratios comparing minority groups to Whites, both overall and separately by age group. We also used a model of monthly COVID-19 deaths to estimate CFR ratios, adjusting for age, gender, and differences across states and time.Results Overall Blacks and Latinx had lower CFRs than Whites. However, when adjusting for age, Blacks and Latinx had higher CFRs than Whites among those younger than 65. CFRs varied substantially across states and time.Conclusions Disparities in COVID-19 case fatality among U.S. Blacks and Latinx under age 65 were evident during the first year of the pandemic. Understanding racial/ethnic differences in COVID-19 CFRs is challenging due to limitations in available data.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data from the COVID Tracking Project are available online at https://covidtracking.com/. The CDC COVID-19 Case Surveillance Public Use Data are available online at https://covid.cdc.gov/covid-data-tracker/. All data files and code used in the analyses reported here are available online at https://github.com/pschumm/covid-modeling.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data files and code used in the analyses reported here are available online at https://github.com/pschumm/covid-modeling. https://github.com/pschumm/covid-modeling